PMG
MRK icon

ProVise Management Group’s Merck MRK Stock Holding History

ProVise Management Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$940K Sell
7,818
-639
-8% -$73.8K 0.07% 139
2025
Q4 		$890K Buy
8,457
+1,526
+22% +$143K 0.06% 141
2025
Q3 		$582K Sell
6,931
-613
-8% -$50.5K 0.04% 162
2025
Q2 		$597K Sell
7,544
-352
-4% -$28K 0.05% 158
2025
Q1 		$709K Sell
7,896
-138
-2% -$12.9K 0.06% 148
2024
Q4 		$799K Sell
8,034
-1,313
-14% -$135K 0.07% 141
2024
Q3 		$1.06M Buy
9,347
+193
+2% +$22.9K 0.08% 147
2024
Q2 		$1.13M Sell
9,154
-36
-0.4% -$4.64K 0.1% 138
2024
Q1 		$1.21M Sell
9,190
-4,324
-32% -$533K 0.11% 137
2023
Q4 		$1.47M Buy
13,514
+199
+1% +$20.7K 0.12% 144
2023
Q3 		$1.37M Buy
13,315
+778
+6% +$83.9K 0.13% 141
2023
Q2 		$1.45M Buy
12,537
+1,196
+11% +$136K 0.13% 144
2023
Q1 		$1.21M Buy
11,341
+1,772
+19% +$191K 0.12% 151
2022
Q4 		$1.06M Buy
9,569
+168
+2% +$17.2K 0.11% 155
2022
Q3 		$810K Buy
9,401
+244
+3% +$21.8K 0.09% 170
2022
Q2 		$835K Sell
9,157
-1,750
-16% -$155K 0.09% 166
2022
Q1 		$895K Sell
10,907
-27,708
-72% -$2.18M 0.08% 181
2021
Q4 		$2.96M Sell
38,615
-64,308
-62% -$5.12M 0.27% 99
2021
Q3 		$7.73M Sell
102,923
-2,979
-3% -$227K 0.76% 33
2021
Q2 		$8.24M Sell
105,902
-6,535
-6% -$486K 0.84% 30
2021
Q1 		$8.27M Buy
112,437
+24,425
+28% +$1.8M 0.89% 24
2020
Q4 		$6.87M Buy
88,012
+63,726
+262% +$4.87M 0.79% 33
2020
Q3 		$1.92M Hold
24,286
– – 0.26% 104
2020
Q2 		$1.79M Sell
24,286
-1,757
-7% -$132K 0.26% 104
2020
Q1 		$1.91M Sell
26,043
-570
-2% -$44.8K 0.32% 89
2019
Q4 		$2.31M Buy
26,613
+147
+0.6% +$12.1K 0.28% 104
2019
Q3 		$2.13M Sell
26,466
-590
-2% -$47.3K 0.28% 103
2019
Q2 		$2.17M Sell
27,056
-2,319
-8% -$178K 0.29% 98
2019
Q1 		$2.33M Sell
29,375
-3,625
-11% -$271K 0.33% 87
2018
Q4 		$2.41M Hold
33,000
– – 0.38% 74
2018
Q3 		$2.23M Buy
33,000
+419
+1% +$26.7K 0.29% 100
2018
Q2 		$1.89K Sell
32,581
-629
-2% -$35.5K 0.14% 130
2018
Q1 		$1.73M Sell
33,210
-419
-1% -$22.6K 0.25% 106
2017
Q4 		$1.8M Sell
33,629
-5,775
-15% -$320K 0.26% 101
2017
Q3 		$2.41M Sell
39,404
-1,314
-3% -$79.7K 0.35% 89
2017
Q2 		$2.49M Buy
40,718
+770
+2% +$46.9K 0.38% 82
2017
Q1 		$2.42M Hold
39,948
– – 0.39% 77
2016
Q4 		$2.24M Sell
39,948
-134
-0.3% -$7.84K 0.38% 84
2016
Q3 		$2.39M Buy
40,082
+1,406
+4% +$82.2K 0.41% 76
2016
Q2 		$2.13M Buy
+38,676
New +$2.06M 0.39% 81

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ProVise Management Group's MRK Position: Q1 2026 in Review

ProVise Management Group reduced its Merck (MRK) stake by 7.6% in Q1 2026, selling an estimated $73.8K and leaving 7,818 shares worth $940K. The position accounts for 0.07% of the portfolio, ranked #139.

ProVise Management Group first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $8.27M in Q1 2021. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • ProVise Management Group held 7,818 shares of Merck worth $940K as of Q1 2026.
  • ProVise Management Group sold 639 Merck shares in Q1 2026, an estimated $73.8K.
  • Merck made up 0.07% of ProVise Management Group's portfolio in Q1 2026, its #139 holding.
  • ProVise Management Group first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
  • ProVise Management Group's Merck position peaked at $8.27M in Q1 2021.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on ProVise Management Group's 13F filing for Q1 2026, filed 7 May 2026.